Health Canada reviewing safety of drospirenone-containing oral contraceptives (Yasmin and Yaz) and risk of venous thromboembolism

Health Canada is currently reviewing two new studies recently published in the British Medical Journal that suggest the risk of blood clots with drospirenone-containing birth control pills may be two to three times greater than with birth control pills containing another type of progestin (levonorgestrel).

For more information,  click here.

x close

Submit your thoughts, ideas, feature requests or bug reports to PANS. The more information you provide us, the more we can improve the website, however only the details field is required.


x close

Log in to access the PANS membership area, or request an account today.

Forgot your password?